News Breaks |
|
|
| November 16, 2012 |
| 07:53 EDT |  | VRX, MRX | Valeant receives FTC clearance for Medicis acquisition
Valeant Pharmaceuticals (VRX) announced that the U.S. Federal Trade Commission, or FTC, has completed its review of the proposed acquisition of Medicis Pharmaceutical Corporation (MRX) by Valeant and has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 without conditions. The grant of early termination is effective as of November 15. The company expects to close the merger within four business days following satisfaction of all closing conditions. |
|
|
News For VRX;MRX From The Last 14 Days Check below for free stories on VRX;MRX the last two weeks. |
|
|
| June 17, 2013 |
| 16:03 EDT |  | VRX | Valeant files to sell $1.75B of common stock
Goldman, Sachs & Co. will act as sole manager of the Offering outside of Canada and Goldman Sachs Canada will act as sole manager of the Offering in Canada. |
|
| June 11, 2013 |
| 07:31 EDT |  | VRX | Goldman to host a conference
 Subscribe for More Information |
|
| June 10, 2013 |
| 10:04 EDT |  | VRX | On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alexandria Real Estate (ARE) upgraded to Buy from Neutral at ISI Group... BB&T (BBT) upgraded to Overweight from Equal Weight at Evercore... CyrusOne (CONE) upgraded to Strong Buy from Outperform at Raymond James... EQT Corporation (EQT) upgraded to Buy from Hold at Brean Capital... Edwards Lifesciences (EW) upgraded to Outperform from Neutral at Credit Suisse... Enersis (ENI) upgraded to Buy from Neutral at Citigroup... Entergy (ETR) upgraded to Buy from Hold at Deutsche Bank... Monsanto (MON) upgraded to Outperform from Neutral at Macquarie... Regency Centers (REG) upgraded to Buy from Neutral at ISI Group... Silver Standard (SSRI) upgraded to Hold from Sell at Deutsche Bank... Standard Pacific (SPF) upgraded to Neutral from Underweight at JPMorgan... Stericycle (SRCL) upgraded to Buy from Hold at Wunderlich... WABCO (WBC) upgraded to Buy from Neutral at Goldman... Western Union (WU) upgraded to Outperform from Market Perform at Raymond James... Weyerhaeuser (WY) upgraded to Outperform from Sector Perform at RBC Capital... Washington Trust Bancorp (WASH) upgraded to Buy from Hold at Sandler O'Neill... EastGroup Properties (EGP) upgraded to Buy from Hold at Sandler O'Neill... Valeant (VRX) upgraded to Buy from Fair Value at CRT Capital... RF Micro Devices (RFMD) upgraded to Strong Buy from Buy at Charter Equity... Bank of the Ozarks (OZRK) upgraded to Outperform from Market Perform at Raymond James... United Community Banks (UCBI) upgraded to Outperform at Raymond James... Western Union (WU) upgraded at Raymond James... CyrusOne (CONE) upgraded to at Raymond James... AT&T (T) upgraded to Buy from Hold at Argus... IMAX (IMAX) upgraded to Buy from Neutral at B. Riley... TriMas (TRS) upgraded to Outperform from Market Perform at Barrington. |
|
| 08:58 EDT | | VRX | Valeant upgraded to Buy from Fair Value at CRT Capital
CRT Capital upgraded Valeant based on valuation and the Bausch + Lomb acquisition. Price target is $100. |
|
| 07:37 EDT | | VRX | Valeant files automatic common shelf offering
Subscribe for More Information |
|
| June 7, 2013 |
| 14:38 EDT | | VRX | Valeant confirms plans for financing of Bausch + Lomb acquisition
As previously disclosed by the company, Valeant has entered into a definitive agreement under which it will acquire Bausch + Lomb Holdings Incorporated. The company confirms its expectation that such transaction will be financed with debt and approximately $1.5B-$2.0B of new equity. Concurrently, Valeant announced the filing of a preliminary base shelf prospectus for up to $3B in common shares. |
|
| 14:30 EDT | | VRX | Valeant announces $3B common stock offering
Subscribe for More Information |
|
|
|
|
|
